Skip to main content

Octomom case changed the fertility industry standards

Image placeholder title

What may seem to most like the obvious, that the medical treatment of Nadya Suleman was unethical, is actually an extraordinary perspective in the little regulated world of infertility treatment. There were actually many doctors and legal commentators who were surprised about Dr. Michael Kamrava's demise.

The Medical Board of California revoked Dr. Michael Kamrava's license this month, a full two years after the octuplets were born under the scrutiny of the world. The censure was uncommon and somewhat unprecedented.

There are no laws in the US or many other countries that limit how many embryos can be implanted into a woman. National guidelines have been created since the Sulman case, but at the time there were few guidelines for what was appropriate. Of course now, many doctors will say that at the time they couldn't have imagined a reputable doctor placing 12 embryos into a middle aged mother of six.

Dr. Kamrava's defense that Suleman should have terminated some of the surviving embryos, while revolting now, seemed a pretty standard defense. He claims he did what he needed to to keep a desperate client happy. She went back on her word to terminate the extra embryos. He threw the responsibility back to her and in fact that is was a standard defense. In fact, he was allowed to continue practicing while under investigation.

Now there are guidelines provided by the Society for Assisted Reproductive Technology which states that the number of embryos should never be increased by more than one depending on the mother's age and other health factors. They have greatly limited the doctor's discretion.

In all, over many years, Suleman was implanted with 60 embryos by Dr. Kamrava. Now the profession agrees with common sense. Octuplets won't easily be created again, not without serious consequences.

Source: Associated Press


Popular Video